CBD brand Naturecan has acquired a production facility in Oregon, USA to increase its capacity and meet growing demand for its products. The acquisition will also allow the company to expand its product offerings and improve its supply chain.
UK-based CBD brand Naturecan has acquired an industrial hemp processing facility in Oregon from hemp genetics company IAH Oregon. The acquisition will provide Naturecan with a reliable supply chain for its CBD products, as well as allowing the company to expand its presence in the US market.
The facility, located in Salem, Oregon, spans 56,000 square feet and is equipped with state-of-the-art processing equipment. It is capable of processing up to 40,000 pounds of industrial hemp per day, with the ability to extract both CBD and other valuable cannabinoids and terpenes.
The acquisition is part of Naturecan’s strategy to establish itself as a leading player in the global CBD market. The company has experienced rapid growth since its founding in 2019, thanks in part to its focus on high-quality, transparently-sourced CBD products.
“We’re excited to be expanding our operations in the US and acquiring such a world-class facility in the process,” said Andy Duckworth, CEO of Naturecan. “This acquisition gives us full control over our supply chain and enables us to continue to deliver premium-quality CBD products to customers around the world.”
The acquisition comes at a time of increasing consolidation in the CBD industry, as companies seek to gain a competitive edge through vertical integration and strategic partnerships. By owning its own production facility, Naturecan will be better positioned to control costs, ensure product quality, and respond to changing market demands.
The US CBD market is expected to continue its rapid growth in the coming years, driven by increasing consumer awareness and demand for natural health and wellness products. With its expanded presence in the US market, Naturecan is well-positioned to capitalize on this trend and establish itself as a leading player in the global CBD industry.
Overall, the acquisition of the IAH Oregon facility represents a significant milestone for Naturecan and underscores the company’s commitment to quality and innovation in the CBD space. As the industry continues to evolve, companies that prioritize transparency, quality, and sustainability will be best positioned to succeed and deliver value to customers.